These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 27556482)

  • 1. Monitoring of Anti-Hepatitis E Virus Antibody Seroconversion in Asymptomatically Infected Blood Donors: Systematic Comparison of Nine Commercial Anti-HEV IgM and IgG Assays.
    Vollmer T; Diekmann J; Eberhardt M; Knabbe C; Dreier J
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27556482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area.
    Wu WC; Su CW; Yang JY; Lin SF; Chen JY; Wu JC
    J Med Virol; 2014 Apr; 86(4):720-8. PubMed ID: 24395716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
    Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
    J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection.
    Avellon A; Morago L; Garcia-Galera del Carmen M; Munoz M; Echevarría JM
    J Med Virol; 2015 Nov; 87(11):1934-9. PubMed ID: 25959136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Hepatitis E Virus (HEV)-antibody tests: a comparative analysis based on samples from individuals with direct contact to domestic pigs or wild boar in Germany.
    Sommerkorn FM; Schauer B; Schreiner T; Fickenscher H; Krumbholz A
    Med Microbiol Immunol; 2017 Jun; 206(3):277-286. PubMed ID: 28397024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors.
    Al-Absi ES; Al-Sadeq DW; Younis MH; Yassine HM; Abdalla OM; Mesleh AG; Hadwan TA; Amimo JO; Thalib L; Nasrallah GK
    J Med Microbiol; 2018 Sep; 67(9):1302-1309. PubMed ID: 30051802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of two immunoassays for serological diagnosis of hepatitis E.
    Sampedro A; Casanovas I; Ceballos J; Rodriguez-Granger J; Cobo F; Navarro JM
    J Med Virol; 2020 Feb; 92(2):260-262. PubMed ID: 31579928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort Study.
    Norder H; Karlsson M; Mellgren Å; Konar J; Sandberg E; Lasson A; Castedal M; Magnius L; Lagging M
    J Clin Microbiol; 2016 Mar; 54(3):549-55. PubMed ID: 26659210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A preliminary study on hepatitis E virus antibody IgG and IgM for the diagnosis of acute hepatitis E].
    Li K; Zhuang H; Zhu W; Ruan B; Jiang J; Li S; Zhai Q; Yao Z; Tang R; Chen Y
    Zhonghua Nei Ke Za Zhi; 1999 Nov; 38(11):733-6. PubMed ID: 11798711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in detection of antibodies against hepatitis E virus in US blood donor samples using commercial assays.
    Zafrullah M; Zhang X; Tran C; Nguyen M; Kamili S; Purdy MA; Stramer SL
    Transfusion; 2018 May; 58(5):1254-1263. PubMed ID: 29520800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients.
    Rossi-Tamisier M; Moal V; Gerolami R; Colson P
    J Clin Virol; 2013 Jan; 56(1):62-4. PubMed ID: 23089569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance Evaluation of Different Commercial Serological Kits for Diagnosis of Acute Hepatitis E Viral Infection.
    Zhang Q; Zong X; Li D; Lin J; Li L
    Pol J Microbiol; 2020 Sep; 69(2):217-222. PubMed ID: 32548990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors.
    Kraef C; Schlein C; Hiller J; Westhölter D; Denzer U; Horvatits T; Peine S; Lohse AW; Lütgehetmann M; Polywka S; Pischke S
    J Clin Virol; 2018 Aug; 105():26-30. PubMed ID: 29860111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of the hepatitis E assay-dependent seroprevalence among Croatian blood donors.
    Miletić M; Vuk T; Hećimović A; Stojić Vidović M; Jemeršić L; Jukić I
    Transfus Clin Biol; 2019 Nov; 26(4):229-233. PubMed ID: 31277986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011.
    Vollmer T; Diekmann J; Eberhardt M; Knabbe C; Dreier J
    Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis E virus serology and PCR: does the methodology matter?
    Cattoir L; Van Hoecke F; Van Maerken T; Nys E; Ryckaert I; De Boulle M; Geerts A; Verhelst X; Colle I; Hutse V; Suin V; Wautier M; Van Gucht S; Van Vlierberghe H; Padalko E
    Arch Virol; 2017 Sep; 162(9):2625-2632. PubMed ID: 28523520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calibrating Hepatitis E Virus Serological Assays Using Asymptomatic Specimens Obtained in Japan.
    Terahara K; Li TC; Matsubayashi K; Sakata H; Kato T; Naganuma A; Ogawa K; Honda K; Itakura J; Akutsu N; Tobita H; Korenaga M; Kanto T; Sugiyama R; Suzuki R; Hamaguchi I; Isogawa M; Takahashi Y
    Microbiol Spectr; 2022 Oct; 10(5):e0214622. PubMed ID: 36125314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are VIDAS® anti-HEV IgM and IgG assays fit for reliable diagnosis of hepatitis E virus infections?
    Cattoir L; Vercauteren KOA; Padalko E; De Beenhouwer H; Van Vaerenbergh K; Boel A
    Acta Clin Belg; 2021 Feb; 76(1):25-31. PubMed ID: 31402757
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of the reliability of two ELISA kits for detecting IgM antibody against hepatitis E virus].
    Zhou H; Jiang CW; Li LP; Zhao CY; Wang YC; Xu YW; Chen XF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):667-71. PubMed ID: 19175178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics of the VIDAS® ANTI-HEV IgM and IgG assays.
    Abravanel F; Goutagny N; Joffray R; Eichenlaub E; Baron S; Aversenq A; Bourg S; Mercier L; Larue Triolet A; Poirault D; Loubet M; Daniel S; Luciani F; Pothion C; Tourneur C; Dugua JM; Lhomme S; Izopet J
    J Clin Virol; 2019 Mar; 112():10-14. PubMed ID: 30658273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.